This topic contains a solution. Click here to go to the answer

Author Question: Compare the relative efficacy of methylphenidate (Ritalin), dietary restrictions (e.g., sugar, food ... (Read 71 times)

theo

  • Hero Member
  • *****
  • Posts: 698
Compare the relative efficacy of methylphenidate (Ritalin), dietary restrictions (e.g., sugar, food additives), and barbiturates in the treatment of the primary symptoms of attention deficit disorders in children.
 
  What will be an ideal response?

Question 2

What differences exist among dextroamphetamine, methylphenidate and pemoline in the treatment of ADHD?
 
  What will be an ideal response?



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

owenfalvey

  • Sr. Member
  • ****
  • Posts: 337
Answer to Question 1

Ritalin reduces the core symptoms of ADHD (impulsivity, distractibility, excessive fidgetiness) in about 60-80 of ADHD children and improves most aspects of their classroom behavior and performance and interactions with their teachers and peers, but does not seem to induce substantial longterm benefits in overall cognitive functioning (e.g., I.Q.). Elimination of potential allergens like food additives and salicylates (e.g., the Feingold diet) seems to benefit a small minority (approximately 5) of ADHD children. Barbiturates (sedative-hypnotics) are not effective at all and may actually be worse than placebo in ADHD children.

Answer to Question 2

Virtually none in terms of clinical efficacy regarding the target symptoms of ADHD or their side effects, although pemoline rarely may induce hepatic toxicity that potentially can be lethal. They differ in potency (d>m>p in terms of potency), but this is of little relevance clinically. The primary advantage of pemoline over the immediate release forms of dextroamphetamine and methylphenidate was its slower onset of action, longer duration of action and lower likelihood of abuse; however, since several sustained release formulations of dextroamphetamine or methylphenidate have been developed, this is no longer a significant factor. The particular type of psychostimulant, particularly the specific sustained release formulation of dextroamphetamine and methylphenidate that is most effective for an individual patient is determined largely on the basis of trial and error.




theo

  • Member
  • Posts: 698
Reply 2 on: Jun 22, 2018
:D TYSM


mcabuhat

  • Member
  • Posts: 344
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

You should not take more than 1,000 mg of vitamin E per day. Doses above this amount increase the risk of bleeding problems that can lead to a stroke.

Did you know?

In the United States, congenital cytomegalovirus causes one child to become disabled almost every hour. CMV is the leading preventable viral cause of development disability in newborns. These disabilities include hearing or vision loss, and cerebral palsy.

Did you know?

Colchicine is a highly poisonous alkaloid originally extracted from a type of saffron plant that is used mainly to treat gout.

Did you know?

Essential fatty acids have been shown to be effective against ulcers, asthma, dental cavities, and skin disorders such as acne.

Did you know?

Disorders that may affect pharmacodynamics include genetic mutations, malnutrition, thyrotoxicosis, myasthenia gravis, Parkinson's disease, and certain forms of insulin-resistant diabetes mellitus.

For a complete list of videos, visit our video library